跳至主要内容
临床试验/NCT01212575
NCT01212575已完成不适用

A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Outpatients With Schizophrenia

AstraZeneca1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
186
试验地点
1
主要终点
How Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia

研究概览

简要总结

The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with a diagnosis of schizophrenia from a district psychiatric clinic in Denmark
  • Patients who have received at least one dose of Seroquel XR or Seroquel IR during January - March 2010

排除标准

  • Patients already participating in a clinical study during the study-period.

结局指标

主要结局

How Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia

时间窗: Month 3

次要结局

  • Co-morbidities of patients with schizophrenia receiving Seroquel XR and IR(Month 3)
  • Whether Seroquel XR and Seroquel IR are used to treat different types of outpatients with schizophrenia by evaluation of patient characteristics(Month 3)
  • The treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR(Month 3)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验